Bourke, who has headed up the Group since 2016, will leave at the end of this year and will be succeeded by Iñaki Ereño, CEO of Bupa Europe and Latin America (ELA), who will take up the post on 1 January 2021.
Bupa chairman Roger Davis said Bourke, who had been chief financial officer at the Group prior to taking over as CEO in 2016, left the organisation in ‘excellent shape’.
‘The hallmark of her leadership has been her systematic focus on Bupa’s customers, putting them front and centre right across the organisation. She has also transformed many of the fundamentals across the Group, investing in technology and operational resilience, and strengthening internal controls and risk management,’ said Davis.
Bourke said her decision to quit the company had ‘not been easy’ and that she had been privileged to lead the Group through a time of ‘significant transformation, challenge and change’. She will now go on to develop a portfolio career.
‘I know that Bupa will go from strength to strength under Iñaki’s leadership, and I’m looking forward to working with him over the coming months as we make the transition,’ she added.
Iñaki Ereño joined Bupa in 2005 and has been CEO of Sanitas since 2008 and CEO of ELA since 2016.
Commenting on his new role, he said: ‘Health could not be more relevant to the world right now, and Bupa has a vital role to play. I know we have what we need to succeed in the future healthcare space. I am delighted to be entrusted with taking us forward and ensuring we rise to this opportunity.’
Davis described Ereño as a ‘natural choice’ to take the group forward.
‘[He] is a long-time member of the Bupa team, with an exemplary track record of leadership, innovation and growth across multiple business lines and geographies… The Board and I are excited about what he will bring to the next chapter in Bupa’s development,’ he added.